Euro-BioImaging diversifies its presence on social media


Published November 12, 2024
Category

Euro-BioImaging recognises the power of social media to promote excellence in the life sciences as well as build and connect the imaging community. We also share concerns about potential harm and unexpected risks from the lack of moderation  on these platforms. That’s why we are diversifying our presence across multiple social media platforms. We want to offer our community members comfortable and safe interaction spaces. 

We will continue using social media for communication while monitoring external risks and our own impact. As an alternative to social media, we encourage you to sign up for our Newsletter to remain informed about the Euro-BioImaging community.

We look forward to connecting with you on the following social media platforms: 

Bluesky: https://bsky.app/profile/eurobioimaging.bsky.social 

Instagram: https://www.instagram.com/eurobioimaging/ 

LinkedIn: https://www.linkedin.com/company/Euro-BioImaging 

X: https://x.com/eurobioimaging/ 

YouTube: https://www.youtube.com/c/eurobioimagingcommunication

Mastodon: https://mastodon.social/@EuroBioImaging 

GitHub: https://github.com/Euro-BioImaging 

Euro-BioImaging on new social media
Euro-BioImaging on new social media

More news from Euro-BioImaging

issue concentration of deuterated glucose and/or fructose

June 30, 2025

Deuterium Metabolic Imaging to measure hepatic fructose metabolism

Chronic intake of high amounts of fructose has been linked to the development of metabolic disorders caused by the almost complete clearance of fructose…

June 30, 2025

VISITING THE PRIME NODE

With the occasion of the Board meeting which took place in Amsterdam last May, the Med-Hub section Director Linda Chaabane and the Med-Hub Head…

CANDLE logo

June 24, 2025

EU Project CANDLE starts building National Cancer Data Nodes

The EU-funded project CANDLE – National CAncer data Node DeveLopErs – officially kicked off on 1st of June 2025, launching its three-year mission to…